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The knowledge on the etiology of breast cancer has advanced substantially in recent years, and several etiological factors are now 
fi rmly established. However, very few new discoveries have been made in relation to occupational risk factors. The International 
Agency for Research on Cancer has evaluated over 900 different exposures or agents to-date to determine whether they are 
carcinogenic to humans. These evaluations are published as a series of Monographs (www.iarc.fr). For breast cancer the follow-
ing substances have been classifi ed as “carcinogenic to humans” (Group 1): alcoholic beverages, exposure to diethylstilbestrol, 
estrogen-progestogen contraceptives, estrogen-progestogen hormone replacement therapy and exposure to X-radiation and 
gamma-radiation (in special populations such as atomic bomb survivors, medical patients, and in-utero exposure). Ethylene ox-
ide is also classifi ed as a Group 1 carcinogen, although the evidence for carcinogenicity in epidemiologic studies, and specifi cally 
for the human breast, is limited. The classifi cation “probably carcinogenic to humans” (Group 2A) includes estrogen hormone 
replacement therapy, tobacco smoking, and shift work involving circadian disruption, including work as a fl ight attendant. If the 
association between shift work and breast cancer, the most common female cancer, is confi rmed, shift work could become the 
leading cause of occupational cancer in women. 
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Descriptive Epidemiology - 
The Burden of Breast Cancer
Breast cancer is the most common malignancy affecting wom-
en worldwide. Indeed, incidence and mortality is elevated in all 
high- and low-and-middle-income countries, with 13.8 million 
new cases in 2008, corresponding to 23% of all cancers. The 
incidence varies greatly, being highest among White women in 
the United States, Australia and New Zealand, and Western 
and Northern Europe (incidence over 80/100,000); and lowest 
among Asian women living in Asia and African women living 
in sub-Saharan Africa (incidence around or below 30/100,000). 
The wide range of female breast cancer mortality rates is less 
marked than variations in incidence, due to better survival in 
high-income countries compared to low-and-middle-income 
countries [1].
Time trends of the incidence of female breast cancer also 
vary markedly worldwide. In general these trends have been in-
creasing over the last 5 decades, including in Asia and Europe. 
In the United States, following a period of steady increase, the 
trend has been declining over the last few years, probably due to 
the interruption of large-scale prescription of hormone replace-
ment therapy in the last decade [2,3]. Mortality trends generally 
follow trends of invasive breast cancer incidence. 
Male breast cancer is a rare disease with incidence rates 
varying from 5 to 15 per 1,000,000. Rates are higher in North 
America and Europe, and extremely low in Asian populations. 
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Indeed, female breast cancer incidence is 100% higher than 
male breast cancer incidence, which represents less than 1% of 
the cancers affecting men worldwide [4]. Studies on the time 
trends of  male breast cancer indicate that its incidence is in-
creasing, mimicking that of female breast cancer, although on a 
much smaller scale [5,6]. 
General Epidemiology and Lifestyle-
Related Risk Factors for Breast Cancer
Female breast cancer
Reproductive factors
Early age at menarche (≤ 11 vs. ≥ 15 years: 1.1-to-1.9-fold in-
creased risk) [7,8], late age at menopause (≥ 55 vs. ≤ 45 years: 
1.1-to-1.9-fold increased risk) [7,8], nulliparity (nulliparous vs. 
parous women: 1-to-2-fold increase in risk; inconclusive after 
1 child) [9], and age at first full-term pregnancy above 30 years 
(1-to-2-fold increased risk compared to women with first full-
term pregnancy before 20 years of  age) [8-13], have all been 
consistently shown to be associated with increased female 
breast cancer risk, although results vary slightly between stud-
ies. There is a suggested protective effect of  lactation (i.e., 
breastfeeding) against both pre and postmenopausal breast 
cancer (Relative risk (RR) 0.98, 95% CI 0.97-1.00 for ever vs. 
never, especially for long-term lactation at a young age) [14,15].
Use of  exogenous hormones
According to the International Agency for Research on Cancer 
(IARC), in-utero exposure to diethylstilbestrol, i.e., when a 
pregnant woman uses the drug, increases a female child’s risk 
of developing breast cancer [16,17]. 
Use of  estrogen-progestogen contraceptives (RR-1.50 
in particular among current vs. never users; increased risk for 
women with benign breast disease, women who used contra-
ceptives in the peri- or postmenopausal period, or women who 
used contraceptives at < 20 years of  age and/or before their 
first full-term pregnancy) [8,9], and use of estrogen-progestogen 
hormone replacement therapy (RR < 2, in particular for wom-
en who took them for several years or in high doses, or women 
> 60 years old) increase breast cancer risk, while hormone 
replacement therapy with estrogen alone (without progestogen) 
is probably associated with an increased risk of developing fe-
male breast cancer [8,9,18-20]. 
Diet, body size, and physical activity
The World Cancer Research Fund (WCRF) [15] evaluated the 
available evidence in relation to diet, physical activity and body 
size in relation to female breast cancer risk. Similar evaluations 
have been carried out earlier on and published in the IARC 
Handbooks of Cancer Prevention [21,22].
Overall, there is limited evidence suggesting that con-
sumption of total fat is associated with postmenopausal breast 
cancer risk [15]. No other dietary factors have been compelling-
ly linked to breast cancer risk either in pre or postmenopausal 
women [15,22]. 
There is consistent epidemiological evidence of  a dose-
response relationship, indicating that high body fatness prob-
ably protects against breast cancer risk among premenopausal 
women (RR 0.94, 95% CI 0.92-0.95 per 2 kg/m2), but the 
mechanistic evidence is speculative [15,21]. In contrast, there is 
consistent epidemiological evidence and a clear dose-response 
relationship, with robust evidence for mechanisms operating 
in humans, indicating that greater body adiposity is associated 
with postmenopausal breast cancer risk (RR 1.50, 95% CI 1.50-
1.60 per 2 kg/m2) [15,21]. Abdominal fatness is associated with 
postmenopausal breast cancer risk (RR 1.19, 95% CI 1.10-1.28 
for waist-to-hip ratio per 0.1 increment), as is adult weight gain 
(RR 1.05, 95% CI 1.04-1.07 per 5 kg gained), whereas high 
birth weight is associated with premenopausal breast cancer 
risk (RR 1.08, 95% CI 1.04-1.13) [15].
In respect to height, there is abundant prospective epi-
demiological evidence, which is generally consistent, of  a 
clear dose-response relationship, and evidence for plausible 
mechanisms in humans (RR 1.03, 95% CI 1.01-1.04 per 5 cm 
increase). There is convincing evidence that factors that lead to 
greater adult attained height, or their consequences, are associ-
ated with risk of  both pre and postmenopausal breast cancer 
[15].
As for physical activity, the evidence from prospective 
studies is inconsistent, but in general suggests that physical 
activity protects against premenopausal breast cancer. There 
is also ample evidence from prospective studies showing a 
lower risk of postmenopausal breast cancer with higher levels 
of physical activity, though there is some heterogeneity in the 
dose-response relationship (RR = 0.97, 95% CI 0.95-0.99 per 7 
metabolic equivalents (METS)-hours per week (METs describe 
intensity relative to a person’s resting metabolic rate). There is 
little evidence on frequency, duration, or intensity of  activity, 
but evidence is robust for mechanisms operating in humans. In 
summary, physical activity probably protects against postmeno-
pausal breast cancer [15,21]. 
Alcoholic beverages
In agreement with the IARC evaluations, which considered 
alcohol as “carcinogenic” (Group 1) to the human breast [23], 
the WCRF also classified the consumption of alcoholic bever-
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ages as “convincingly increasing risk” for both pre and post-
menopausal breast cancer, irrespective of the type of alcoholic 
beverage (i.e., no difference between wine, beer, liquor, etc.). A 
dose-response relationship is apparent: all studies able to ana-
lyze dose-response found an increase in risk with increasing al-
cohol consumption (RR 1.10, 95% CI 1.06-1.14 per 10 g/day). 
In addition no threshold was identified, and there is robust 
evidence for mechanisms operating in humans [15].
Tobacco smoking
There is limited evidence with inconsistent results suggesting 
that tobacco smoking is associated with female breast cancer 
risk, in particular when smoking starts early, and before a wom-
an’s first full-term pregnancy (before the breast tissue matures) 
and continues for several decades [23,24].
Ionizing radiation
The IARC classified X-radiation and gamma-radiation as car-
cinogenic agents with sufficient evidence in humans in relation 
with female breast cancer risk (2-4-fold increase in risk for high 
doses compared to minimal exposure; risk may be higher when 
exposure occurs from puberty to child bearing years, when 
breast tissue is proliferating) [9,25]. However, the evidence 
on which the evaluation was based emanates from studies in 
special populations, such as atomic bomb survivors, medical 
patients; and women who were exposed in-utero (offspring of 
atomic bomb survivors and pregnant medical patients) [26]. A 
recent study from Korea [27] does not suggest an increase in 
breast cancer risk among women with occupational exposure 
to ionizing radiation. 
Electromagnetic fi elds
Recent studies, including meta and pooled analyses, do not 
support the hypothesis that exposure to electromagnetic fields 
increases female breast cancer risk [28-34]. Goodman et al. 
reviewed how spurious confounding could have biased risk es-
timates in early studies [35].
Family history of  breast cancer and genetic susceptibility
Family history of breast cancer increases female breast cancer 
risk substantially depending on the age at diagnosis of the af-
fected relatives, the age of the woman and the number of affect-
ed relatives, and the generational distance of the relatives to the 
women (1st degree relative with premenopausal bilateral breast 
cancer > 4-fold increase in risk (Yes vs. No); one 1st degree rela-
tive with any form of breast cancer 2-4-fold increase in risk (Yes 
vs. No); two 1st degree relatives with any form of breast cancer 
RR > 4-fold increase in risk) [7-13,36,37]. In recent years sev-
eral large-scale genetic studies have been carried out. Besides 
mutations in high-penetrance genes, such as BRCA1, BRCA2, 
TP53, PTEN, STK11, and CDH1, variations in moderate- and 
low-penetrance genes have been identified as increasing female 
breast cancer risk to various degrees (RRs range from 1.00 to 
1.40) [37]. However, only a minority of  familial relative risk, 
defined as the ratio of the risk of disease for a relative of an af-
fected individual to that of the general population, is explained 
by genetic variants discovered to-date [37].
Male breast cancer
Following Bernardino Ramazzini’s report of an increased oc-
currence of  breast cancer among nuns more than 300 years 
ago, Domenico Antonio Rigoni-Stern made the same obser-
vation among male priests in 1842 [38,39]. One and a half 
centuries later, the etiology of male breast cancer is still rather 
poorly understood. This may be due to the relative rarity of 
male breast cancer incidence, and consequently, the scarcity of 
published studies. Genetic, hormonal, and environmental risk 
factors have been reported to be associated with male breast 
cancer risk. Family history of breast cancer has been associated 
with increased risk of male breast cancer in several studies. In 
particular, genetic susceptibilities related to male breast cancer 
include mutations in BRCA1, BRCA2 and possibly other genes 
(Cyp17, AR, CHEK2). Kleinefelter’s syndrome and a few oth-
er rare disorders also seem to be associated with risk. Similarly, 
associations with education, religion, marital status, clinical 
disorders related to hormonal imbalance (infertility, testicular 
injury, liver lesions, and gynecomastia), and estrogen intake are 
controversial. Among the environmental exposures studied, 
alcohol consumption and related liver cirrhosis, heavy tobacco 
smoking, and obesity were associated with increased male 
breast cancer risk in a few studies, but results are equivocal. 
There are insufficient studies to allow any conclusions about 
the effect of exposure to ionizing radiation or electromagnetic 
fields on male breast cancer [4,39-48]. 
Occupational exposures and breast cancer risk
According to the IARC, there are no agents with sufficient evi-
dence in humans that can be classified as “carcinogenic to hu-
mans” (Group 1) to the human breast which could be consid-
ered directly occupationally related. Although ethylene oxide is 
classified as a Group 1 carcinogen, the evidence for carcinoge-
nicity in epidemiologic studies, and specifically for the human 
breast, is limited. Shift work that involves circadian disruption 
is classified as “probably carcinogenic to humans” (Group 2A) 
based on epidemiological evidence on breast cancer occurrence 
in occupationally exposed groups [49]. 
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Human exposure to ethylene oxide occurs mainly during the 
sterilization of medical equipment, although ethylene oxide is 
also used for the production of some chemicals. Although the 
epidemiological evidence was deemed “limited”, the IARC 
Working Group classified ethylene oxide as a Group 1 car-
cinogen, taking into consideration the studies on mechanisms 
of carcinogenicity and studies in animal models [50,51]. The 
IARC evaluation was based mainly on an internal analysis in a 
study of 7,500 women [52], which showed a significant dose-
response relationship between ethylene oxide exposure and 
female breast cancer incidence, with the risk doubling among 
women with higher cumulative exposures. However, an in-
crease in female breast cancer risk has not been consistently 
reported in other studies [50,51]. 
Shift work involving circadian disruption
The IARC evaluation [49,53] of  female breast cancer was 
based on relatively few studies in humans (only 9, 6 of which 
found an association). These studies used very different defini-
tions of shift work, and different methodologies: two were pro-
spective cohort studies [54,55], one was a nationwide census-
based cohort study [56], three were nested case-control studies 
[57-59], and two were retrospective case-control studies [60,61]. 
These studies basically included only Caucasian postmeno-
pausal women. The main occupational categories included 
in these studies were nurses, marine telephone operators and 
female flight attendants. There were several methodological 
weaknesses in these studies, particularly relating to the defini-
tion of shift work [49,62,63]. 
Clearly more studies in humans are needed to allow a 
thorough understanding of  the possible association between 
shift work and breast cancer risk, and to assess the details of a 
possible relationship, which could lead to preventive measures. 
These studies should have strong methodological planning and 
execution, and should include different ethnic groups as well as 
premenopausal women. Moreover, they should include several 
industry groups that use shift work, and pay particular attention 
to the classification and measurement of patterns of shift work. 
When reaching conclusions about potential carcinogenicity to 
humans, the IARC evaluation [49] carefully considered the bio-
logical mechanisms of carcinogenicity as well as the sufficient 
evidence in experimental animals regarding the carcinogenicity 
of light during night time (biological night). 
A recent study reported that of all female breast cancers 
in the United Kingdom, 4.6% could be attributed to shift work. 
The study further estimated that the nearly 2,000 registered 
breast cancer cases due to shift work corresponded to 54.0% of 
all registered occupation-related female cancer cases [64]. Giv-
en the large proportion of women working irregular hours and 
doing shift work worldwide, as well as the very high incidence 
rates of female breast cancer in general, more research is clearly 
needed both to confirm the association between shift work and 
breast cancer, as well as to answer several questions related to 
the patterns of the association. Future research should investi-
gate if  different patterns of shift work are similarly harmful; if  
exposure to shift work in a particular period of life (for example 
before first full-term pregnancy) is especially harmful; if  there 
are interactions between shift work with other lifestyle factors, 
such as alcohol consumption, physical activity, or body size 
and shape; if  women who does shift work should be screened 
more frequently than the general population; if  there is a dose-
response relationship in terms of number of years (or numbers 
of  days/nights per month) spent doing shift work and breast 
cancer risk, and, if  so, if  policy makers should regulate the 
maximum amount of  years women are allowed to work in 
shifts [65].
Other inconclusive exposures
Most of the studies on occupation or occupational exposures 
and breast cancer risk were carried out using self-administered 
questionnaires or registry linkages to job titles, and derived oc-
cupational exposures via job exposure matrixes. 
Several epidemiological studies have been published 
reporting the association between specific occupational cat-
egories or job titles in relation to female breast cancer risk. The 
methodology in these studies varies widely, as do the results 
[66-68]. Confounding due to lifestyle factors was not always 
taken into account, making the overall pattern of association 
rather unclear. For example, exposures to solvents [69], manu-
facturing of chemicals where known or potential carcinogens 
are used such as vinyl chloride, 1,3-butadiene, benzene, nitrosa-
mines, and other solvents [70]; service industries including the 
health care industry [70]; and studies among religious workers 
[71], military personnel, dentists, journalists, physicians, ad-
ministrators and artistic workers [68], laboratory technicians, 
telephone and telegraph operators, leather and fur processors, 
glass manufacturing workers, inspectors, analysts [72], teachers 
[73,74], librarians and counselors [74] have all been reported to 
be associated to female breast cancer risk in at least one study. 
Studies among air crews, particularly flight attendants, 
were also evaluated by the IARC [49]. These studies tended to 
show an increase in female breast cancer risk. They do, how-
ever present some methodological problems, such as lack of 
controlling for the possible confounding effect of occupation-
related lifestyle factors also known to be associated with breast 
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cancer risk (such as alcohol consumption, lower parity and 
late age at first full-term pregnancy). The possibility of breast 
cancer over-diagnosis due to more frequent mammography 
screening than the general population also cannot be ruled out. 
Moreover, an air crew is exposed to cosmic radiation, the effect 
of which has been suggested to increase female breast cancer 
risk [49].
Regarding male breast cancer, the largest study pub-
lished so far on specific job titles was carried out in the Nordic 
countries, and reported a higher than expected standardized 
incidence rate among journalists, cooks, stewards, printers, 
artistic workers and building caretakers. Intriguingly, the com-
mon characteristic of these professions is that they are usually 
performed in shifts [68]. A recent case-control study in Europe 
found increased male breast cancer risk, especially among mo-
tor vehicle mechanics (OR 2.10, 95% CI 1.00-4.40), with sus-
pect exposures to organic petroleum solvents, petrol and poly-
cyclic aromatic hydrocarbons [75]. The male breast cancer risk 
for exposure to alkylphenolic compounds, known endocrine 
disrupting chemicals, also increased (OR 3.80, 95% CI 1.50-
9.50) [75]. 
Breast Cancer and Occupation 
- Final Considerations
So far the literature is not clear about the specific clinical and 
pathological features of  breast cancer possibly related to oc-
cupation, nor are there any molecular markers that can be used 
specifically to identify occupational exposures related to breast 
cancer. Likewise, there are no genetic susceptibility tests that 
can be used to screen women particularly susceptible to occu-
pational exposure-related breast cancer.
Breast cancer risk is obviously influenced by a number of 
hormonal factors and may be influenced by endocrine-disrupt-
ing agents. These exposures may be mediated by environmen-
tal determinants, such as lifestyle (hormonal therapies, diet, 
alcohol consumption, and smoking), work schedule (e.g., shift 
work), and various medical conditions. It is interesting to note 
that while there are multiple toxicants and hormone-mimicking 
compounds which can alter mammary gland development in 
rodents, and even cause cancer in some experimental rodent 
models, there are not many that have been shown to do so in 
humans. This may be due to the lack of ability to measure the 
exposures in the right time frame. As the mammary gland has 
certain critical periods during development, adverse effects 
may necessitate the presence of  carcinogens during the short 
window of time when the structures of the gland are sensitive. 
These toxicants could lead to an increase in the incidence of 
mammary tumors if  they alter circulating or tissue-localized 
hormone levels. This can happen through mechanisms such as 
hormonal disrupting agents, agents with hormonal influences, 
alkylating carcinogens capable of causing mutations in critical 
genes during key stages of development, or influences on hor-
mone transport and receptor expression patterns. 
While there are many critical periods during the mamma-
ry gland development, and a large array of potential toxicants 
which may be able to act as cancer causing agents under some 
conditions in experimental models, it is ultimately the obser-
vations in humans that will dictate if  what is possible from a 
theoretical point of view can be realized in real-life conditions. 
The issues involved, such as the possible interactions between 
potential risk factors, including critical exposures early in life 
and during breast gland development, and the great diversity of 
breast cancer itself, are very complex and challenging to study 
in humans.
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